After skin cancer, cancer of the prostate, the walnut-sized gland that produces semen, is the most common form of cancer among men in the United States. More than 238,000 men will be diagnosed with the disease in 2013, according to the American Cancer Society. Fortunately, when prostate cancer is detected early, treatment can be highly effective.
The Barbara and Maurice Deane Prostate Health and Research Center, part of the Department of Urology at The Mount Sinai Health System, provides the most up-to-date services available for the diagnosis, treatment, and management of prostate cancer.
The physicians on the staff of the Deane Center are fellowship-educated clinicians and researchers who are renowned for their expertise and innovation in current and emerging treatment for prostate cancer. Our surgeons are among the few trained in open, laparoscopic, and robotic prostate surgery.
In addition, Mount Sinai is considered one of the premiere centers for brachytherapy and intensity-modulated radiation therapy (IMRT). Brachytherapy, which Mount Sinai helped to pioneer, and IMRT are advanced types of high-precision radiation treatment that deliver radiation doses more precisely while minimizing damage to nearby normal tissues.
This combination of expertise makes our physicians uniquely qualified to recommend the optimal approach for each patient and to achieve outcomes that are among the best anywhere.
We Can Help
Please call us at 212-241-4812 to learn how our physicians can provide an in-depth evaluation to ensure optimal treatment for you or your loved one based on your medical profile and needs.
Bill Weinzimmer sought out Mount Sinai's expertise when he was faced with an advanced prostate cancer diagnosis. Learn more